Health
Lonza confident of 2020 target for Moderna COVID-19 vaccine supply – Devdiscourse
There is no approved COVID-19 vaccine yet, but several are in advanced trials, including from Pfizer Inc, Johnson & Johnson and Moderna, whose candidate relies …
Lonza is confident that U.S. and Swiss plants it is building to help make Moderna’s COVID-19 vaccine candidate will be ready for commercial production this year, executives at the Swiss company said on Tuesday.
New production lines at Lonza’s site in Portsmouth, New Hampshire, aim to start making vaccine ingredients in November, while three lines in Visp, deep in a valley in the Swiss Alps – to supply 300 million vaccine doses annually – should begin delivering by December. There is no approved…
-
Noosa News23 hours agoInside the final hours before Australian lawyer Christopher Saines died in Thai massage parlour
-
General21 hours agoGerman backpacker Carolina Wilga found alive in WA’s outback
-
Noosa News23 hours agoGrow it local | Noosa Today
-
Noosa News23 hours agoAustralian NFL player Laki Tasi comes home to convince kids to switch codes